Tirzepatide

https://www.helloklarity.com/wp-content/uploads/2022/07/Klarity-Logo-Brand.svg

Klarity Health, Inc

Home

Tirzepatide Prescription Online: Same-Day Appointment

Tirzepatide is the active ingredient in 2 brand-name medications, Mounjaro and Zepbound. It’s also available as a compounded medication. It was first approved by the U.S. Food and Drug Administration (FDA) as Mounjaro in 2022 to improve blood sugar (glucose) control in people with type 2 diabetes.

People taking Mounjaro also lost weight. So Mounjaro’s manufacturer, Eli Lilly, got Zepbound FDA-approved for weight loss in 2023. Zepbound and Mounjaro are the same medication, just approved for different uses. Zepbound is approved for people with a body mass index (BMI) of 30 or more, or people with a BMI of 27 or more and at least 1 weight-related health condition, such as type 2 diabetes, high cholesterol, or high blood pressure (hypertension).

Whether you use compounded tirzepatide, Mounjaro, or Zepbound, you should eat a reduced-calorie diet and get more exercise.